Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics Statistics

Total Valuation

DFTX has a market cap or net worth of $2.29 billion. The enterprise value is $2.00 billion.

Market Cap	2.29B
Enterprise Value	2.00B

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

DFTX has 109.07 million shares outstanding. The number of shares has increased by 19.43% in one year.

Current Share Class	109.07M
Shares Outstanding	109.07M
Shares Change (YoY)	+19.43%
Shares Change (QoQ)	+7.71%
Owned by Insiders (%)	0.93%
Owned by Institutions (%)	63.15%
Float	108.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.97
P/TBV Ratio	8.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.15.

Current Ratio	4.69
Quick Ratio	4.60
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.57

Financial Efficiency

Return on equity (ROE) is -94.70% and return on invested capital (ROIC) is -42.82%.

Return on Equity (ROE)	-94.70%
Return on Assets (ROA)	-35.72%
Return on Invested Capital (ROIC)	-42.82%
Return on Capital Employed (ROCE)	-60.39%
Weighted Average Cost of Capital (WACC)	17.26%
Revenue Per Employee	n/a
Profits Per Employee	-$2.24M
Employee Count	106
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +220.95% in the last 52 weeks. The beta is 2.38, so DFTX's price volatility has been higher than the market average.

Beta (5Y)	2.38
52-Week Price Change	+220.95%
50-Day Moving Average	20.56
200-Day Moving Average	14.72
Relative Strength Index (RSI)	46.56
Average Volume (20 Days)	1,840,830

Short Selling Information

The latest short interest is 9.36 million, so 8.58% of the outstanding shares have been sold short.

Short Interest	9.36M
Short Previous Month	9.82M
Short % of Shares Out	8.58%
Short % of Float	8.66%
Short Ratio (days to cover)	4.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-193.37M
Pretax Income	-237.54M
Net Income	-237.54M
EBITDA	n/a
EBIT	-193.37M
Earnings Per Share (EPS)	-$2.49

Balance Sheet

The company has $373.42 million in cash and $40.77 million in debt, with a net cash position of $332.65 million or $3.05 per share.

Cash & Cash Equivalents	373.42M
Total Debt	40.77M
Net Cash	332.65M
Net Cash Per Share	$3.05
Equity (Book Value)	278.85M
Book Value Per Share	2.68
Working Capital	299.45M

Cash Flow

Operating Cash Flow	-144.77M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	20.00M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DFTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.43%
Shareholder Yield	-19.43%
Earnings Yield	-10.20%
FCF Yield	n/a

Analyst Forecast

The average price target for DFTX is $38.38, which is 82.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$38.38
Price Target Difference	82.85%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 29, 2022
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1